The purpose of this legislation is to reverse certain changes made to Medicaid cost-sharing requirements and to the exclusion of orphan drugs under the Medicare Drug Price Negotiation Program. The bill aims to protect patients from increased healthcare costs associated with these changes. Key provisions of the legislation include the repeal of specific sections of a previous law that altered how Medicaid cost-sharing works. This means that the original rules regarding how much patients have to pay out-of-pocket for Medicaid services will be reinstated.